Abstract
Implants of defatted, freeze‐dried Saos‐2 human osteosarcoma cells grown to confluency induce de novo bone formation in athymic mice. These cells are also richly endowed with bone morphogenetic proteins and express mRNA for bone morphogenetic proteins 1, 2, 3, 4, and 6, as well as for transforming growth factor‐β1. Our aim was to study whether the ability to induce bone formation is related to the level of expression of bone morphogenetic protein. We studied the osteoinductive abilities and levels of expression of bone morphogenetic protein of Saos‐2 cells both during the growth phase and after confluency was reached. Subconfluent cells were at least 70% less effective in their osteoinductive ability than confluent cells. Comparison of bone morphogenetic protein mRNA expression in confluent and subconfluent cells revealed that the latter had lower expression of all the mRNAs studied. The expression of bone morphogenetic protein‐1, bone morphogenetic protein‐2, and bone morphogenetic protein‐6 mRNAs was 2, 3, and 6 to 10‐fold lower, respectively, in subconfluent cells. These results suggest that the ability of Saos‐2 cells to induce de novo bone formation may be correlated with the relative expression of these proteins; the expression of bone morpho‐genetic proteins in Saos‐2 cells also may be dependent on the cell cycle.